Try the modernized beta website. Learn more about the modernization effort.

Key Record Dates Identifier: NCT02712112
Brief Title: A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs

First Submitted : March 9, 2016
First Submitted that Met QC Criteria : March 14, 2016
First Posted : March 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : October 12, 2021
Last Update Posted : October 20, 2021